Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.07, $0.06 better than the analyst estimate of $2.01. Revenue for the quarter came in at $2.18 billion versus the consensus estimate of $2.14 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2026 EPS of $8.47-$8.59, versus the consensus of $8.47.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.